Cognitive deficits are a core symptom of schizophrenia and marked in the sub-domains of cognition. They have been shown to predict whether a patient will be able to meet functional goals. Because of the small effect size of pharmacotherapy on cognitive function, cognitive remediation has gradually been introduced into the psychiatric rehabilitation. This non-pharmacological treatment for improving neurocognition aims to enhance the neurocognitive strategies relevant to their chosen recovery goals through engaging the participants in learning activities in a highly motivated way. Most meta-analytic studies on this new treatment report moderate effect sizes on cognition with the notable differences in their effects possibly due to their distinct practice methods. The impact of this treatment on daily functioning, however, has been found to be smaller than that on neurocognitive skills. It is thus suggested that cognitive remediation should be implemented in concert with other types of programs for psychiatric rehabilitation.